Nichole Musumeci

Researcher Spotlight: Suchitra Sundaram, MD The Mount Sinai Icahn School of Medicine Over the past several years, targeted therapy with small molecule inhibitors and antibodies has replaced chemotherapy as the standard treatment for patients with chronic lymphocytic leukemia (CLL). Despite…

Researcher Spotlight: Jason Romancik, MD Emory University – Winship Cancer Institute Follicular lymphoma (FL) is typically a slow-growingor indolent form of non- Hodgkin lymphoma (NHL)that arises from B-lymphocytes, making it a B-celllymphoma. FL is generally very responsive to radiationand chemotherapy, and most…

Researcher Spotlight: Erin Mulvey, MD Weill Cornell Medical College   Diffuse large B-cell lymphoma (DLBCL) and follicularlymphoma (FL) are the two most common types of non-Hodgkin lymphoma, with one categorized as aggressive (fast-growing) and one considered indolent (slow-growing), respectively.First-line treatment for DLBCL…

Researcher Spotlight: Luis Malpica Castillo, MD The University of Texas M.D. Anderson Cancer Center Adult T-cell leukemia/lymphoma (ATLL) is an aggressive, generally incurable type of non-Hodgkin lymphoma (NHL) caused by infection with the human T-cell leukemia virustype 1 (HTLV-1). This…

Researcher Spotlight: Arushi Khurana, M.B.B.S Mayo Clinic, Rochester, MN More than two-thirds of the newly diagnosed Diffuselarge B-cell lymphoma (DLBCL) patients are excluded from participating in clinical trials, without considering the structural and attitudinal barriers that preclude clinical trial participation. Over the…

Researcher Spotlight: P. Connor Johnson, MD Massachusetts General Hospital Older adults with fast-growing lymphomas are often treated with chemotherapy which has the potential to cure some of these diseases. However, understanding which patientswill have serious side effects, complications, and loss…

Researcher Spotlight: David A. Bond, MD The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital  Diffuse large B-cell lymphoma (DLBCL) is the mostcommon type of non-Hodgkin lymphoma (NHL). SinceDLBCL can advance quickly, it usually requires immediatetreatment, which…

Researcher Spotlight: Nicole Prutsch, PhD Dana-Farber Cancer Institute T-cell lymphomas represent a heterogeneous group of peripheral and cutaneous non-Hodgkin lymphomas (NHL) with a range of unmet clinical needs. Anaplastic large cell lymphoma (ALCL) is a CD30+ subtype of non-Hodgkin T-cell…